Carbamoylcholine homologs: Synthesis and pharmacology at nicotinic acetylcholine receptors

European Journal of Pharmacology

Volumn 497, Issue 2, 2004, Pages 125-137

  Jensen, Anders A ^a   Mikkelsen, Ivan ^a   Frølund, Bente ^a   Frydenvang, Karla ^a   Brehm, Lotte ^a   Jaroszewski, Jerzy W ^a   Bräuner Osborne, Hans ^a   Falch, Erik ^a   Krogsgaard Larsen, Povl ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acetylcholine; Agonist; Carbamoylcholine homolog; Muscarinic; Nicotinic acetylcholine receptor

Indexed keywords

3 (N,N DIMETHYLAMINO)BUTYL N,N DIMETHYLCARBAMATE; ACETYLCHOLINE; CARBACHOL; N,N DIMETHYL[2 (DIMETHYLAMINOCARBONYLOXYMETHYL)CYCLOPENTYL]AMMONIUM; N,N DIMETHYL[3 (DIMETHYLAMINOCARBONYLOXY) 1 METHYLPROPYL]AMMONIUM; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EMBRYO; ENANTIOMER; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; X RAY CRYSTALLOGRAPHY;

EID: 4143125626     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.038     Document Type: Article

References (50)

1. 3H]Methylcarbamylcholine, a new radioligand for studying brain nicotinic receptors Biochem. Pharmacol. 35 1986 4199 4202
2. 3H] methylcarbamylcholine in rat brain Eur. J. Pharmacol. 253 1994 261 267
3. S.P. Arneric, and J.D. Brioni Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities 1999 Wiley-Liss New York, NY
4. E.R. Baker, R. Zwart, E. Sher, and N.S. Millar Pharmacological properties of the α9α10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras Mol. Pharmacol. 65 2004 453 460
5. 3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine Biochemistry 41 2002 10262 10269
6. E.R. Bissell, and M. Finger Fluorine-containing nitrogen compounds: I. Trifluoroethylamines J. Org. Chem. 24 1959 1256 1259
7. R.H. Blessing Data reduction and error analysis for accurate single-crystal diffraction intensities Crystallogr. Rev. 1 1987 3 58
8. R.H. Blessing DREADDâ€"data reduction and error analysis for single-crystal diffractometer data J. Appl. Crystallogr. 22 1989 396 397
9. K. Brejc, W.J. van Dijk, R.V. Klaassen, M. Schuurmans, J. van Der Oost, A.B. Smit, and T.K. Sixma Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors Nature 411 2001 269 276
10. P.-J. Corringer, N. Le Novère, and J.-P. Changeux Nicotinic receptors at the amino acid level Annu. Rev. Pharmacol. Toxicol. 40 2000 431 458
11. 3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors Neuropharmacology 38 1999 679 690
12. G.T. DeTitta ABSORB: an absorption correction programme for crystals enclosed in capillaries with trapped mother liquor J. Appl. Crystallogr. 18 1985 75 79
13. F. Dörje, J. Wess, G. Lambrecht, R. Tacke, E. Mutschler, and M.R. Brann Antagonist binding profiles of five cloned human muscarinic receptor subtypes J. Pharmacol. Exp. Ther. 256 1991 727 733
14. A.J.M. Duisenberg Indexing in single-crystal diffractometry with an obstinate list of reflections J. Appl. Crystallogr. 25 1992 92 96
15. Duisenberg, A.J.M., 1998. EvalCCD. PhD thesis, University of Utrecht, The Netherlands.
16. L.P. Dwoskin, and P.A. Crooks Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery J. Pharmacol. Exp. Ther. 298 2001 395 402
17. R.M. Eglen, A. Choppin, and N. Watson Therapeutic opportunities from muscarinic receptor research Trends Pharmacol. Sci. 22 2001 409 414
18. J.-L. Eiselé, S. Bertrand, J.-L. Galzi, A. Devillers- Thiéry, J.-P. Changeux, and D. Bertrand Chimaeric nicotinic†"serotonergic receptor combines distinct ligand binding and channel specificities Nature 366 1993 479 483
19. Enraf-Nonius CAD-4 Software, Version 5.0 1989 Enraf-Nonius Delft, The Netherlands
20. R.W. Fitch, Y. Xiao, K.J. Kellar, and J.W. Daly Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function Proc. Natl. Acad. Sci. U. S. A. 100 2003 4909 4914
21. C. Gotti, D. Fornasari, and F. Clementi Human neuronal nicotinic receptors Prog. Brain Res. 53 1997 199 237
22. 6 by 3-dimethylaminopropylamine, 2-(dimethylaminomethyl)cyclopentylamines, and polyethylenimines J. Am. Chem. Soc. 96 1974 835 845
23. M.W. Holladay, M.J. Dart, and J.K. Lynch Neuronal nicotinic acetylcholine receptors as targets for drug discovery J. Med. Chem. 40 1997 4169 4194
24. J.W. Jaroszewski, L. Matzen, B. Frølund, and P. Krogsgaard-Larsen Neuroactive polyamine wasp toxins: nuclear magnetic resonance spectroscopic analysis of the protolytic properties of philanthotoxin-343 J. Med. Chem. 39 1996 515 521
25. A.A. Jensen, I. Mikkelsen, B. Frølund, H. Bräuner-Osborne, E. Falch, and P. Krogsgaard-Larsen Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors Mol. Pharmacol. 64 2003 865 875
26. C.K. Johnson ORTEP II Report ORNL-5138. A Fortran Thermal-Ellipsoid Plot Programme for Crystal Structure Illustrations 1976 Oak-Ridge National Laboratory Tennessee, USA
27. A. Karlin Emerging structure of the nicotinic acetylcholine receptors Nat. Rev., Neurosci. 3 2002 102 114
28. R. Kinas, K. Pankiewicz, W.J. Stec, P.B. Farmer, A.B. Foster, and M. Jarman Synthesis and absolute configuration of the optically active forms of 2-[bis(2-chloroethyl)amino]-4-methyltetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide (4-methylcyclophosphamide) J. Org. Chem. 42 1977 1650 1652
29. E.D. Levin Nicotinic receptors in the nervous system S.A. Simon M.A.L. Nicolelis Methods and New Frontiers in Neuroscience 2002 CRC Press Boca Raton
30. J. Lindstrom Nicotinic acetylcholine receptors in health and disease Mol. Neurobiol. 152 1997 193 222
31. Nonius COLLECT 1999 Nonius Delft, The Netherlands
32. M.J. Parker, A. Beck, and C.W. Luetje Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity Mol. Pharmacol. 54 1998 1132 1139
33. D. Paterson, and A. Nordberg Neuronal nicotinic receptors in the human brain Prog. Neurobiol. 61 2000 75 111
34. as Anal. Chem. 68 1996 2127 2134
35. J.S. Punzi, S. Banerjee, and L.G. Abood Structureâ€" activity relationships for various N-alkylcarbamyl esters of choline with selective nicotinic cholinergic properties Biochem. Pharmacol. 41 1991 465 467
36. 3H]MK-801 binding to the N-methyl-d-aspartate receptor-ion channel complex by l-glutamate, glycine, and polyamines J. Neurochem. 51 1988 830 836
37. M.N. Romanelli, and F. Gualtieri Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications Med. Res. Rev. 23 2003 393 426
38. K. Sabey, K. Paradiso, J. Zhang, and J.H. Steinbach Ligand binding and activation of rat nicotinic α4β2 receptors stably expressed in HEK293 cells Mol. Pharmacol. 55 1999 58 66
39. C.G. Sharples, S. Kaiser, L. Soliakov, M.J. Marks, A.C. Collins, M. Washburn, E. Wright, J.A. Spencer, T. Gallagher, P. Whiteaker, and S. Wonnacott UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes J. Neurosci. 20 2000 2783 2791
40. G.M. Sheldrick SHELXS-86. Program for the Solution of Crystal Structures 1986 University of Göttingen Göttingen, Germany
41. G.M. Sheldrick Phase annealing in SHELX-90: direct methods for larger structures Acta Crystallogr. A46 1990 467 473
42. G.M. Sheldrick SADABS. Program for Absorption Correction Bruker AXS Analytical X-ray Systems, Madison, Wisconsin, USA 1996
43. G.M. Sheldrick SHELXL97. Program for Crystal Structure Refinement 1997 University of Göttingen Göttingen, Germany
44. G.M. Sheldrick SHELXS97. Program for the Solution of Crystal Structures 1997 University of Göttingen Göttingen, Germany
45. N.M. Silva, J.L. Tributino, A.L. Miranda, E.J. Barreiro, and C.A. Fraga New isoxazole derivatives designed as nicotinic acetylcholine receptor ligand candidates Eur. J. Med. Chem. 37 2002 163 170
46. B. Søkilde, I. Mikkelsen, T.B. Stensbøl, B. Andersen, S. Ebdrup, P. Krogsgaard-Larsen, and E. Falch Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors Arch. Pharm. Pharm. Med. Chem. 329 1996 95 104
47. M. Tulp, and L. Bohlin Functional versus chemical diversity: is biodiversity important for drug discovery? Trends Pharmacol. Sci. 23 2002 225 231
48. A.J.C. Wilson International Tables for Crystallography, Vol. C; Tables 4.2.6.8 and 6.1.1.4 1995 Kluwer Academic Dordrecht, The Netherlands
49. Y. Xiao, E.L. Meyer, J.M. Thompson, A. Surin, J. Wroblewski, and K.J. Kellar Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function Mol. Pharmacol. 54 1998 322 333
50. W. Zhong, J.P. Gallivan, Y. Zhang, L. Li, H.A. Lester, and D.A. Dougherty From ab initio quantum mechanics to molecular neurobiology: a cationâ€"Ï€ binding site in the nicotinic receptor Proc. Natl. Acad. Sci. U. S. A. 95 1998 12088 12093